Maximus (MMS)
(Delayed Data from NYSE)
$91.38 USD
+0.10 (0.11%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $90.74 -0.64 (-0.70%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$91.38 USD
+0.10 (0.11%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $90.74 -0.64 (-0.70%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Zacks News
Earnings Preview: Maximus (MMS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Booz Allen Hamilton (BAH) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Booz Allen (BAH) delivered earnings and revenue surprises of 4.90% and 4.01%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Is Maximus (MMS) Up 1.4% Since Last Earnings Report?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MAXIMUS (MMS) Stock Up 20% Since Q4 Earnings & Revenue Beat
by Zacks Equity Research
MAXIMUS (MMS) fourth-quarter fiscal 2022 earnings and revenues surged year over year.
Maximus (MMS) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 37.25% and 7.85%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
IBEX Limited (IBEX) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
IBEX Limited (IBEX) delivered earnings and revenue surprises of 17.24% and 1.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
ICF International (ICFI) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
ICF (ICFI) delivered earnings and revenue surprises of 11.81% and 0.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Investors Should Retain Maximus (MMS) Stock Now
by Zacks Equity Research
Solid track record of dividend payments boosts Maximus (MMS).
Maximus (MMS) Down 5.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MAXIMUS (MMS) Misses on Q3 Earnings, Trims '22 EPS View
by Zacks Equity Research
MAXIMUS's (MMS) third-quarter 2022 earnings and revenues decline year over year.
Maximus (MMS) Misses Q3 Earnings Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of -20.41% and 3.38%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Booz Allen Hamilton (BAH) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Booz Allen (BAH) delivered earnings and revenue surprises of 6.60% and 2.97%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Reasons to Retain Maximus (MMS) Stock in Your Portfolio For Now
by Zacks Equity Research
With more than 40 years of experience, Maximus (MMS) has grown to be a leading operator of government health and human services programs globally.
Maximus (MMS) Down 5.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MAXIMUS (MMS) Q2 Earnings Top, Stock Down 8.8% on Tepid EPS View
by Zacks Equity Research
MAXIMUS (MMS) second-quarter fiscal 2022 earnings fall, while revenues rise year over year.
Maximus (MMS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 9.18% and 8.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Reasons to Add Maximus (MMS) Stock to Your Portfolio Now
by Zacks Equity Research
With more than 40 years of experience, Maximus has grown to be a leading operator of government health and human services programs globally.
Wall Street Analysts See a 31% Upside in Maximus (MMS): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at a 31.3% upside potential for Maximus (MMS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Maximus (MMS) Up on Strategic Acquisitions Amid High Debt
by Zacks Equity Research
Maximus' (MMS) expertise in business process management, and its ability to deliver cost-effective, efficient and high-scale solutions, position it as a lucrative partner to governments.
Wall Street Analysts See a 33% Upside in Maximus (MMS): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at a 33.3% upside potential for Maximus (MMS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
MAXIMUS (MMS) Beats on Q1 Earnings, Raises '22 Revenue View
by Zacks Equity Research
MAXIMUS's (MMS) first-quarter 2022 earnings and revenues improve year over year.
Maximus (MMS) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 40% and 5%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Maximus (MMS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Investors Should Retain Maximus (MMS) Stock Now
by Zacks Equity Research
Strategic acquisitions and investor-friendly measures boost Maximus (MMS) stock. However, high debt is a headwind.
Investor-Friendly Steps Aid MAXIMUS (MMS), High Debt Ails
by Zacks Equity Research
MAXIMUS (MMS) rides on solid shareholder-friendly measures and strategic acquisitions. However, a high debt balance is a concern.